Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial

OBJECTIVE: To evaluate whether the addition of colchicine to standard of care (SOC) results in better outcomes in hospitalized patients with COVID-19. DESIGN: This interventional, multicenter, randomized, phase 2 study, evaluated colchicine 1.5 mg/day added to SOC in hospitalized COVID-19 patients (...

Descripción completa

Detalles Bibliográficos
Autores principales: Perricone, Carlo, Scarsi, Mirko, Brucato, Antonio, Pisano, Paola, Pigatto, Erika, Becattini, Cecilia, Cingolani, Antonella, Tiso, Francesco, Prota, Roberto, Tomasoni, Lina Rachele, Cutolo, Maurizio, Tardella, Marika, Rozza, Davide, Zerbino, Carlo, Andreoni, Massimo, Poletti, Venerino, Bartoloni, Elena, Gerli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618432/
https://www.ncbi.nlm.nih.gov/pubmed/36396522
http://dx.doi.org/10.1016/j.ejim.2022.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618432/
https://www.ncbi.nlm.nih.gov/pubmed/36396522
http://dx.doi.org/10.1016/j.ejim.2022.10.016

Ejemplares similares